US health regulator the United States Food and Drug Administration (USFDA) has said it will import cancer drug Lipodox from India’s Sun Pharma to meet the shortage of another similar medicine Doxil.
In response to the critical shortage of the cancer drug Doxil and rapidly declining supplies of methotrexate, the USFDA took proactive steps needed to increase available supply for patients in the US.
“For Doxil, there will be temporary importation of a replacement drug, Lipodox which is expected to end the shortage and fully meet patient needs in the coming weeks,” USFDA said on its website.
